A comprehensive review of the literature on epilepsy in selected countries in emerging markets

Mallik Angalakuditi1, Nupur Angalakuditi21Georgia State University, Atlanta, GA; 2New York Medical College, Valhalla, NY, USAAims: To perform a systematic literature review of studies in peer reviewed journals on the epidemiology, economics, and treatment patterns of epilepsy in selected countries i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Angalakuditi M, Angalakuditi N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/09e304104b9440cc84a64ea3fefa998c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:09e304104b9440cc84a64ea3fefa998c
record_format	dspace
spelling	oai:doaj.org-article:09e304104b9440cc84a64ea3fefa998c2021-12-02T08:20:42ZA comprehensive review of the literature on epilepsy in selected countries in emerging markets1176-63281178-2021https://doaj.org/article/09e304104b9440cc84a64ea3fefa998c2011-09-01T00:00:00Zhttp://www.dovepress.com/a-comprehensive-review-of-the-literature-on-epilepsy-in-selected-count-a8385https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Mallik Angalakuditi1, Nupur Angalakuditi21Georgia State University, Atlanta, GA; 2New York Medical College, Valhalla, NY, USAAims: To perform a systematic literature review of studies in peer reviewed journals on the epidemiology, economics, and treatment patterns of epilepsy in selected countries in emerging markets.Methods: A literature search was performed using relevant search terms to identify articles published from 1999 to 2000 on the epidemiology, economics, and treatment patterns of epilepsy. Studies were identified through electronic Embase&reg;, Cochrane&copy;, MEDLINE&reg;, and PubMed&reg; databases. Manual review of bibliographies allowed for the detection of additional articles.Results: Our search yielded 65 articles. These articles contained information relevant to epidemiology (n = 16), treatment guidelines (n = 4), treatment patterns (n = 33), unmet needs (n = 4), and economics (n = 8). From a patient perspective, patients with less than or equal to two adverse events (AEs) while taking anti-epileptic drugs (AEDs) had significantly lower annual costs than those having greater than or equal to three AEs, as did patients with fewer seizures. The overall mean annual cost for epilepsy per patient ranged from US$773 in China to US$2646 in Mexico. Prevalence data varied widely and were found for countries including Arab League Members, China, India, and Taiwan. In Turkey, active prevalence rates ranged from 0.08/1000 to 8.5/1000, and in Arab countries, active prevalence ranged from 0.9/1000 in Sudan to 6.5/1000 in Saudi Arabia. Seventeen different AEDs were used in the identified studies. The most common AEDs utilized were phenobarbital (21.7%), valproate (17.5%), and tiagabine (16.4%). In all studies, the use of AEDs resulted in an increase of patients who became seizure free and a reduction in seizure frequency and severity.Conclusion: Few studies have examined the prevalence and incidence of epilepsy in emerging markets and study limitations tend to underestimate these rates at all times. More cost-effectiveness, cost-minimization, and cost-benefit analyses must be performed to enhance the data on the economics of epilepsy and its therapy in regions with insufficient resources and those emerging markets which contain the majority of the world&#39;s population. And finally, the study found that generic AEDs are frequently used to successfully treat patients with epilepsy in emerging markets.Keywords: emerging markets, epilepsy, seizures, epidemiology, treatment patterns, guidelines, economicsAngalakuditi MAngalakuditi NDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2011, Iss Issue 1, Pp 585-597 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Angalakuditi M Angalakuditi N A comprehensive review of the literature on epilepsy in selected countries in emerging markets
description	Mallik Angalakuditi1, Nupur Angalakuditi21Georgia State University, Atlanta, GA; 2New York Medical College, Valhalla, NY, USAAims: To perform a systematic literature review of studies in peer reviewed journals on the epidemiology, economics, and treatment patterns of epilepsy in selected countries in emerging markets.Methods: A literature search was performed using relevant search terms to identify articles published from 1999 to 2000 on the epidemiology, economics, and treatment patterns of epilepsy. Studies were identified through electronic Embase&reg;, Cochrane&copy;, MEDLINE&reg;, and PubMed&reg; databases. Manual review of bibliographies allowed for the detection of additional articles.Results: Our search yielded 65 articles. These articles contained information relevant to epidemiology (n = 16), treatment guidelines (n = 4), treatment patterns (n = 33), unmet needs (n = 4), and economics (n = 8). From a patient perspective, patients with less than or equal to two adverse events (AEs) while taking anti-epileptic drugs (AEDs) had significantly lower annual costs than those having greater than or equal to three AEs, as did patients with fewer seizures. The overall mean annual cost for epilepsy per patient ranged from US$773 in China to US$2646 in Mexico. Prevalence data varied widely and were found for countries including Arab League Members, China, India, and Taiwan. In Turkey, active prevalence rates ranged from 0.08/1000 to 8.5/1000, and in Arab countries, active prevalence ranged from 0.9/1000 in Sudan to 6.5/1000 in Saudi Arabia. Seventeen different AEDs were used in the identified studies. The most common AEDs utilized were phenobarbital (21.7%), valproate (17.5%), and tiagabine (16.4%). In all studies, the use of AEDs resulted in an increase of patients who became seizure free and a reduction in seizure frequency and severity.Conclusion: Few studies have examined the prevalence and incidence of epilepsy in emerging markets and study limitations tend to underestimate these rates at all times. More cost-effectiveness, cost-minimization, and cost-benefit analyses must be performed to enhance the data on the economics of epilepsy and its therapy in regions with insufficient resources and those emerging markets which contain the majority of the world&#39;s population. And finally, the study found that generic AEDs are frequently used to successfully treat patients with epilepsy in emerging markets.Keywords: emerging markets, epilepsy, seizures, epidemiology, treatment patterns, guidelines, economics
format	article
author	Angalakuditi M Angalakuditi N
author_facet	Angalakuditi M Angalakuditi N
author_sort	Angalakuditi M
title	A comprehensive review of the literature on epilepsy in selected countries in emerging markets
title_short	A comprehensive review of the literature on epilepsy in selected countries in emerging markets
title_full	A comprehensive review of the literature on epilepsy in selected countries in emerging markets
title_fullStr	A comprehensive review of the literature on epilepsy in selected countries in emerging markets
title_full_unstemmed	A comprehensive review of the literature on epilepsy in selected countries in emerging markets
title_sort	comprehensive review of the literature on epilepsy in selected countries in emerging markets
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/09e304104b9440cc84a64ea3fefa998c
work_keys_str_mv	AT angalakuditim acomprehensivereviewoftheliteratureonepilepsyinselectedcountriesinemergingmarkets AT angalakuditin acomprehensivereviewoftheliteratureonepilepsyinselectedcountriesinemergingmarkets AT angalakuditim comprehensivereviewoftheliteratureonepilepsyinselectedcountriesinemergingmarkets AT angalakuditin comprehensivereviewoftheliteratureonepilepsyinselectedcountriesinemergingmarkets
_version_	1718398524397191168

A comprehensive review of the literature on epilepsy in selected countries in emerging markets

Ejemplares similares